Ameriprise’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.55M | Buy |
|
|||||
|
2025
Q1 | $522K | Sell |
|
|||||
|
2024
Q4 | $682K | Sell |
|
|||||
|
2024
Q3 | $1.54M | Sell |
|
|||||
|
2024
Q2 | $2.98M | Sell |
|
|||||
|
2024
Q1 | $6.74M | Buy |
|
|||||
|
2023
Q4 | $6.69M | Sell |
|
|||||
|
2023
Q3 | $14.7M | Sell |
|
|||||
|
2023
Q2 | $41.8M | Sell |
|
|||||
|
2023
Q1 | $47.2M | Buy |
|
|||||
|
2022
Q4 | $41.3M | Sell |
|
|||||
|
2022
Q3 | $42.8M | Buy |
|
|||||
|
2022
Q2 | $24.9M | Sell |
|
|||||
|
2022
Q1 | $27M | Buy |
|
|||||
|
2021
Q4 | $33.1M | Buy |
|
|||||
|
2021
Q3 | $30.4M | Buy |
|
|||||
|
2021
Q2 | $34.4M | Buy |
|
|||||
|
2021
Q1 | $33.5M | Buy |
|
|||||
|
2020
Q4 | $33.7M | Sell |
|
|||||
|
2020
Q3 | $23.8M | Buy |
|
|||||
|
2020
Q2 | $15.5M | Sell |
|
|||||
|
2020
Q1 | $17.4M | Buy |
|
|||||
|
2019
Q4 | $24.5M | Sell |
|
|||||
|
2019
Q3 | $63.8M | Sell |
|
|||||
|
2019
Q2 | $85.1M | Buy |
|
|||||
|
2019
Q1 | $56.9M | Buy |
|
|||||
|
2018
Q4 | $24.1M | Sell |
|
|||||
|
2018
Q3 | $46.3M | Sell |
|
|||||
|
2018
Q2 | $56.3M | Buy |
|
|||||
|
2018
Q1 | $49.5M | Buy |
|
|||||
|
2017
Q4 | $29.5M | Buy |
|
|||||
|
2017
Q3 | $3.91M | Buy |
|
|||||
|
2017
Q2 | $4.72M | Buy |
|
|||||
|
2017
Q1 | $4.18M | Sell |
|
|||||
|
2016
Q4 | $3.02M | Sell |
|
|||||
|
2016
Q3 | $3.48M | Buy |
|
|||||
|
2016
Q2 | $1.75M | Buy |
|
|||||
|
2016
Q1 | $411K | Buy |
|
|||||
|
2015
Q4 | $646K | Sell |
|
|||||
|
2015
Q3 | $1.54M | Sell |
|
|||||
|
2015
Q2 | $2.75M | Buy |
|
|||||
|
2015
Q1 | $750K | Buy |
|